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Edited by Stuart FergusonAbstract P-glycoprotein (ABCB1) is an ATP-binding cassette
protein that is associated with the acquisition of multi-drug resis-
tance in cancer and the failure of chemotherapy in humans.
Structural insights into this protein are described using a combi-
nation of small angle X-ray scattering data and cryo-electron
crystallography data. We have compared the structures with bac-
terial homologues, and discuss the development of homology
models for P-glycoprotein based on the bacterial Sav1866 struc-
ture.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Multidrug resistance; Membrane protein; Protein
structure; Electron crystallography; SAXS; ABCB11. Introduction
The ATP-binding cassette (ABC) family of proteins [1–5]
comprise a minimal functional unit of two transmembrane do-
mains (TMDs) and two nucleotide binding domains (NBDs).
The TMDs are composed of multiple membrane-spanning a-
helices that interact together to form the binding site(s) for
the transported allocrite and the translocation pathway across
the lipid bilayer. The NBDs power the translocation process
via ATP binding, hydrolysis and nucleotide release [1,2]. To
date, only low to medium resolution three dimensional struc-
tures have been obtained for eukaryotic ABC proteins using
electron microscopy (EM) [3,5,6]. Currently, a maximum reso-
lution of 8 A˚ [6] has been attained for the nucleotide bound
form of mammalian P-glycoprotein (ABCB1) and 20 A˚ for
the nucleotide free state [7,8]. In contrast high resolution struc-
tures of six bacterial ABC transporters have been solved,Abbreviations: SAXS, small angle X-ray scattering; EM, electron
microscopy; ABC, ATP-binding cassette; NBD, nucleotide binding
domain; TMD, transmembrane domain; ICL, intracytoplasmic loop;
DDM, dodecyl maltoside; SDS–PAGE, sodium dodecyl sulphate–
polyacrylamide gel electrophoresis
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[9–16]. However, only Sav1866 and MsbA have been identiﬁed
as putative exporters, a function shared by eukaryotic ABC
transporters. This similarity is supported by amino acid se-
quence comparisons of eukaryotic ABC proteins with the bac-
terial ABC proteins for which structural data is available [9–
16], with Sav1866 as currently the closest homologue as a basis
for homology models.
Recombinant human ABCB1 expressed in insect cell lines
has previously yielded highly active protein [17–19], but in
insuﬃcient quantities for structural methods such as small an-
gle X-ray scattering (SAXS). Improvements in yield and purity
are described herein. SAXS data can be used to provide low
resolution models of proteins and protein complexes that are
often validated by EM [20,21]. However, SAXS studies can
also be used to enhance EM structural data by obtaining a sep-
arate measure of the radially averaged amplitude proﬁle [22].
The SAXS data can also correct for the rapid fall-oﬀ of ampli-
tudes with resolution with EM data. Noise and errors in EM
maps can also be reduced by exploiting any symmetry in the
structure. Where symmetry is coincident with a crystal axis
(crystallographic symmetry), reciprocal space averaging of
the amplitudes is carried out [23]. For other cases, e.g. non-
crystallographic symmetry, it is possible to use real-space aver-
aging [24–26].
In this article, we have employed both SAXS and symmetry
averaging to improve electron crystallography data for
ABCB1 and to help in the interpretation of the resultant den-
sity map. This has provided further insights into the ABCB1
map when interpreted in the context of the Sav1866 model.2. Methods
2.1. Protein expression and puriﬁcation
The Trichoplusia ni (High Five) cell line was maintained in shaking
suspension cultures as previously described [17]. Cells at a density of
3 · 106 cells ml1 were infected with recombinant baculovirus
(5 · 107 plaque-forming units ml1) at a multiplicity of infection of
10. After 2 h of incubation with virus, the cells were diluted to a density
of 1.5 · 106 cells ml1 and grown for a further 3 days before harvesting
by centrifugation (2000 · g, 10 min). Crude membrane preparations
were isolated as previously described [27], with the exception that buf-
fers contained 20 mM MOPS, pH 7.4, 200 mM NaCl, 0.25 M sucrose.
Membranes were solubilised in 20 mMMOPS, pH 7.4, 200 mM NaCl,
1.5 mM MgCl2, 20% glycerol buﬀer containing 2% (w/v) dodecyl mal-
toside (DDM) and 0.4% (w/v) lipid (4:1 Escherichia coli lipid:choles-
terol) and protease inhibitors (Roche, UK) for 60 min at 4 C andblished by Elsevier B.V. All rights reserved.
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tants were fractionated using a 5 ml HisTrap column with a stepwise
gradient from 40 to 800 mM imidazole. Selected fractions were concen-
trated using centrifugal ultraﬁltration concentrators (Millipore, UK,
100 kDa cut-oﬀ). Gel permeation chromatography was performed in
20 mM MOPS, pH 7.4, 200 mM NaCl, 5 mM TCEP, 5% glycerol,
0.02% DDM on a Superdex S200 column 10/30 at a ﬂow rate of
0.3 ml min1. Protein determination was performed using the BioRad
DC Brad protein determination kit with a BSA-calibrated standard
curve and with absorbance measured at 750 nm on a Hitachi U200
spectrophotomer. Sodium dodecyl sulphate–polyacrylamide gel elec-
trophoresis (SDS–PAGE) gels were stained using PAGE-Blue (Fer-
mentas, UK).
2.2. SAXS data collection and model generation
SAXS data were recorded at station 2.1 of the Daresbury SRS, UK
using a wavelength of 1.54 A˚ and a sample-to-detector distance of 1 m
as described in [28]. Data was collected for a total of 20 min in 60s
batches, which allowed for monitoring of any deleterious eﬀects due
to exposure to the beam. A similar dataset was collected for the buﬀer
alone and subtraction of the contribution due to buﬀer was carried out.
No change in the scattering proﬁle of neither ABCB1 nor buﬀer was
identiﬁed over the data collection period.
Model 3D density distributions were produced ab initio using the
GASBOR software [29] which uses simulated annealing to ﬁnd poly-
mer chain-compatible spatial distributions of dummy residues which
ﬁt the experimental SAXS proﬁle. The degree of correspondence be-
tween the experimental SAXS data for ABCB1 and the theoretical
solution scattering proﬁles of the density distributions generated by
the GASBOR program was good (see Supplementary Fig. 1). The re-
sults of 22 GASBOR runs were averaged using the DAMMAVER pro-
gram [30] to produce a 3D probability map which was then ﬁltered
using DAMFILT to a cut-oﬀ volume calculated to include the ex-
pected protein mass, core glycosylation and detergent.
2.3. Correction of the EM derived map and model ﬁtting
A volume containing one molecule within the ABCB1 EM-derived
map was interactively selected using the Chimera software [31], and
then pasted into a 120-pixel box for further manipulation using the
SPIDER [32] and EMAN [33,34] image processing software suites.
The radially averaged structure factor amplitudes were adjusted to
match the SAXS amplitude proﬁle (see Fig. 1c) and then applied toFig. 1. (a) IMAC puriﬁcation of dodeca-histidine tagged ABCB1. The solid
(containing 1 M imidazole). SDS–PAGE with PAGE-blue staining of fract
400 mM imidazole, are displayed on the right. (b) Superdex S200 column fra
preceded by a void volume peak at 8 ml and followed by a large peak corresp
is shown on the right. (c) Small angle X-ray scattering (SAXS) proﬁle for D
smoothed ﬁt (solid line) to the measured data. Superimposed (scattered data p
of P-gp in the presence of AMP–PNP. For comparison, the two sets of datathe original map [33,34]. The Sav1866 structure [9] (backbone atoms)
was initially ﬁtted by hand, and then the local position was reﬁned
by using the Chimera ﬁt model to map function. The Fourier shell
correlation (FSC) was calculated between the map and a 180 rotated
version of it in order to assess the degree of approximation to C2 sym-
metry. This procedure was repeated after small (2 increment) rota-
tions of the map in order to ﬁnd the optimal pseudo-C2 symmetry
axis, which was within 5 of the initial position.3. Results and discussion
3.1. ABCB1 puriﬁcation
Solubilised insect cell membranes were analysed by IMAC
(Fig. 1a). Dodeca-histidine tagged ABCB1 eluted at an imidaz-
ole concentration of 400 mM. SDS–PAGE indicated that the
protein was 80–90% pure. The peak fractions were concen-
trated and further puriﬁed by gel permeation chromatography
(Fig. 1b). A peak containing ABCB1 emerged at 12 ml as well
as a smaller peak corresponding to the void volume of the col-
umn (8 ml) which was due to aggregated ABCB1. The SDS–
PAGE analysis indicates that small amounts of ABCB1 are
present in this initial aggregation peak. The large peak ob-
served at 18–26 ml corresponds to imidazole. The fractions
11.5–12.5 ml were combined and concentrated to 5–
10 mg ml1 for the SAXS analysis. Dynamic light scattering
of the concentrated protein sample (data not shown) con-
ﬁrmed its monodispersity prior to SAXS analysis. Puriﬁed,
detergent solubilised human P-gp does not display measurable
ATPase activity. However, reconstitution of the puriﬁed pro-
tein, as previously described [18–20], resulted in high rates of
drug stimulated ATP hydrolysis (data not shown).
3.2. SAXS data
The SAXS proﬁle for a 6 mg ml1 ABCB1 preparation di-
luted in the gel permeation chromatography buﬀer is shownline is the absorbance at 280 nm and the broken line is the % buﬀer B
ions from 184 to 204 ml, corresponding to the main elution peak at
ctionation of the IMAC-puriﬁed ABCB1. The main peak at 12 ml is
onding to imidazole (18–26 ml). SDS–PAGE for the indicated fractions
DM-solubilised ABCB1 in the presence of AMP–PNP represented as
oints) are the EM-derived structure factor amplitudes from 2D crystals
have been normalised in the middle of the resolution range.
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(s < 0.008 A˚1) between protein batches were detected and
are due to the presence of oligomers (dimers, and higher aggre-
gates) in solution as a result of the protein concentration used.
This region of the scattering curve which is associated with
intermolecular distances does not aﬀect the EM data adjust-
ment. However, for ab initio generation of density distribu-
tions from the SAXS data, a second dataset was recorded
for the low angle scattering region at a 10-fold lower protein
concentration. The two datasets were then merged to allow a
fuller sampling of reciprocal space (see Supplementary
Fig. 1). At about s  0.025 A˚1, an undulation in the SAXS
proﬁle was observed that may be partly due to the presence
of a detergent belt surrounding the protein. In contrast, free
detergent micelles contribute very little at 0.02% (w/v) DDM
– (data not shown). Compared to the SAXS proﬁle, there is
some suppression of the low resolution EM amplitudes, prob-
ably as a result of the CTF. There is also a more noticeable
fall-oﬀ of EM-derived amplitudes at higher resolution.
Low resolution density distributions consistent with the
SAXS proﬁle of ABCB1 were calculated and the averaged dis-
tribution displays a shape approximating a prolate ellipsoid,
with overall dimensions of 150 · 70 · 55 A˚ (Fig. 2). The
maximum diameter Dmax and the radius of gyration were cal-
culated as 149 and 49 A˚, respectively. The unsymmetrised
structure has a compact globular region of 55 A˚ diameterFig. 2. Orthogonal views of the ab initio-generated low resolution 3D
density distribution calculated using the SAXS proﬁle for ABCB1 and
applying no symmetry (top, green surface) or C2 symmetry (bottom,
yellow semi-transparent surface). The latter data is compared with an
optimised ﬁt with the bacterial ABC transporter Sav1866 (ribbon
trace). Regions of the Sav1866 structure that lie within the calculated
density distribution are indicated by the green outline, whilst regions
lying outside the boundaries are highlighted in purple.at the bottom, but has a more open and branched appearance
at the top. After orientation along the long axis, C2 symmetry
was applied to the density distribution. Automated ﬁtting with
the bacterial ABC transporter protein Sav1866 gave an unam-
biguous alignment of the Sav1866 NBDs with the lower region
and its TMDs with the branched upper region. There is a good
agreement at very low resolution between the two sets of struc-
tural information, but it is diﬃcult to say whether at ﬁner de-
tail, the discrepancies observed in Fig. 2 could be due to real
diﬀerences between ABCB1 and Sav1866 structures. Ambigu-
ity in the modelling by GASBOR arises mainly because of
the absence of the phase component from the SAXS data,
but to some extent this is overcome by generating several inde-
pendent models and then averaging them [29].
3.3. ABCB1 structure after correction using the SAXS data
EM data has phase information but the amplitude informa-
tion is distorted. Hence we corrected the distortions using the
well deﬁned amplitude information from SAXS of ABCB1.
Fig. 3 shows a single ABCB1 molecule within the 8 A˚-resolu-
tion map after such correction. Compared to the previously
published map [6], the SAXS-corrected map showed better def-
inition of peripheral features of the EM map, e.g. the extracel-
lular loop regions and the NBDs. Two features that were
previously ﬁtted as short alpha helical elements on the extracel-
lular surface [6] are consistent with extensions of transmem-
brane helices, as observed for the Sav1866 structure.
Fitting the Sav1866 structure, initially manually and then
automatically with the Chimera ﬁt to map routine [31],
yielded a good correspondence between the Sav1866 structure
(backbone atoms) and the ABCB1 map (Fig. 3, right hand pa-
nel). The average density value of the map at the locations of
the 4624 backbone atoms of Sav1866 was 0.82r above the
mean. In comparison, other ABC proteins with less homology
to ABCB1 yielded poorer ﬁts. The 4296 backbone atoms of
BtuCD [13], and the 5180 backbone atoms of ModABC [11],
have values of 0.64 and 0.65r above the mean (respectively).
As previously noted [6], the ABCB1 map shows an approxima-
tion to non-crystallographic (NCS) two-fold symmetry.Fig. 3. ABCB1 map at 8 A˚ resolution after global correction of
experimental amplitudes with the SAXS proﬁle shown in Fig. 1. The
panels show the unsymmetrised map using blue, pink and red netting
to represent density at 1, 2 and 4r above the mean level, respectively.
The panel on the right shows the bacterial homologue, Sav1866 ﬁtted
to the map (white Ca trace). Sav1866 transmembrane domain helices 1,
2, 3 (and 5 from the opposite monomer) are indicated. The scale bar
corresponds to 20 A˚.
Fig. 4. Map sections (1 nm thick) parallel to the pseudo-NCS axis. The left-hand sections are after application of two-fold rotational symmetry
about the (vertical) NCS axis, with blue netting at 2r above the mean density and purple netting at 6r. The right-hand sections in each panel show the
corresponding unsymmetrised map superimposed, using yellow and red netting to represent density at 2 and 6r above the mean level, respectively. In
each case, the bacterial homologue, Sav1866 is ﬁtted to the map (white Ca trace), and the TM helices numbered. Sections equidistant from the C2
symmetry axis through the rear, and front of the map are shown in the panels on the right. The scale bar corresponds to 20 A˚.
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metrised map versus a 180-rotated version of it was carried
out, and a FSC = 0.5 value was passed at a resolution of about
23 A˚. In comparison with other membrane proteins that have
arisen by gene duplication [35] this seemed reasonable. For
example, the L and M subunits of the Rhodopseudomonas
sphaeroides photosynthetic reaction centre (sequence identity
30%) display an overall C2 symmetry to about 21 A˚ [36]
whilst the A and B subunits of cyanobacterial photosystem I
(sequence identity 44%) display C2 symmetry to about
12 A˚ [37]. Consequently, we applied real space averaging to
facilitate comparison with the Sav1866 structure [9]. Features
in the ABCB1 map that are not related by symmetry will be
smeared out, but the exercise allowed a comparison of the
overall footprint of ABCB1 versus the equivalent Sav1866 re-
gions.
A section along the pseudo-C2 symmetry axis is shown in
Fig. 4. The NBD region at the bottom shows two heart-shaped
lobes of density that match the expected NBD structure. Addi-
tional features may be due to the linker region between NBD1
and TMD2 and/or the C-terminus of ABCB1 (blue arrows).
The centre of the TMD region shows a V shaped proﬁle with
a good match between cylindrical densities and Sav1866 TM
helices 3. A central density is not occupied by the ﬁtted
Sav1866 model (blue arrow, see also Fig. 4). The position of
the membrane-spanning region in Sav1866 is indicated by
the dashed lines. Interestingly, densities protrude outwards in
the ABCB1 map at the expected lipid bilayer boundaries (red
arrows). In Sav1866 [9], an N-terminal amphipathic helix is
in a position consistent with it being embedded into the cyto-plasmic surface of the membrane and therefore adds signiﬁcant
density in this boundary region. Two sections taken equidis-
tant from the C2 symmetry axis are also displayed in Fig. 4.
The discrimination between the two halves of the ABCB1 mol-
ecule is clear from these sections, with a leftwards tilt to the
TMD in the rearmost section and to the right in the front sec-
tion (lower panel). The position of the intracytoplasmic loop
(ICL) between helices 4 and 5 in Sav1866 that makes contact
with the opposing NBD is indicated by the yellow ellipse in
the upper panel. The ABCB1 map shows density in this region.
A region not matched by the Sav1866 model in the ICL region
is indicated by the blue arrows. Fig. 5 shows three sections
from the ABCB1 map taken perpendicular to the C2 symmetry
axis and representing the TMD, ICL and NBD regions. For
each section, the unsymmetrised map and symmetrised maps
are again compared. The map in the NBD region is consistent
with a closed dimer conﬁguration, as expected for nucleotide-
bound protein [2,38,39]. The overall footprint of Sav1866 in
this region is similar to the density in the ABCB1 map, and
the expected position of the adenine ring of the AMP–PNP
molecules in Sav1866 is indicated by the red arrows. In
Sav1866, the cytoplasmic loop between TM helices 4 and 5
forms contacts with the opposing NBD [9]. As discussed
above, there is density present in the ABCB1 map in the ex-
pected position of this loop (yellow ellipses). In the ICL region,
the footprint of Sav1866 again matches the ABCB1 map and
any asymmetry in this region (arrows) is likely to arise from
the linker region connecting NBD1 to TMD2.
In the membrane-spanning region, most of the Sav1866 heli-
ces map into available density in the unsymmetrised ABCB1
Fig. 5. Sections (1 nm thick) perpendicular to the pseudo-NCS axis.The upper panels show the map after application of two-fold rotational
symmetry and the lower panels show the corresponding section of the unsymmetrised map superimposed, with netting as in Fig. 3. In each case, the
bacterial homologue, Sav1866 is ﬁtted to the map (white Ca trace). Slices through the transmembrane, intracytoplasmic loop and nucleotide binding
domains are shown left, centre and right, respectively. Sav1866 transmembrane domain helices are indicated in the top left panel. The scale bar
corresponds to 20 A˚.
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and one of the two transmembrane helices 2 which falls in a
gap on the periphery of the ABCB1 map (green ellipse). As
previously reported [6], peripheral densities are somewhat
asymmetrical (blue arrow), and a gap on one side of the pro-
tein is closed on the other side. At the centre of the ABCB1
map, the two transmembrane helices 6 of Sav1866 would have
to move about 5 A˚ inwards to give a good ﬁt. Data obtained
previously by cross-linking of inserted cysteine residues sug-
gests that helices 6 and 12 are indeed close together in ABCB1
[40,41]. The same technique also identiﬁes a close association
of helices 2 and 11 and 5 and 8 in ABCB1 [42,43], consistent
with the arrangement of these helices (2 and 5) in the
Sav1866 homodimer [9].
A homology model for ABCB1 based on the bacterial
Sav1866 structure has already been published [44]. Eukaryotic
NBD structures will be similar to their bacterial counterparts
[38,45–47], but for the TMD regions, homology at the level
of primary through to tertiary structure could be weak. The
six bacterial ABC proteins yielding high resolution structural
information, show surprising TMD plasticity (three distinct
folds are evident) [9–16]. Moreover, recent data show that
two identical TMDs can adopt slightly diﬀerent structures
when a periplasmic protein is bound [12]. If such plasticity
and asymmetry is at work in eukaryotic ABC proteins, then
modelling the crucial TMD regions will be challenging. The
work presented here, however, demonstrates that modelling
of eukaryotic transporters on the basis of bacterial counter-
parts is likely to be productive, especially where experimental
validation of models of eukaryotic ABC proteins is possibleusing a combination of low to medium resolution structural
methods such as SAXS and EM.Acknowledgements: We thank Drs. Ian Kerr (University of Notting-
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